Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Blood|December 16, 2006
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V Moorman, Christine J Harrison, Georgina A N Buck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular TherapyZachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Blood|May 4, 2013
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemiaCourtney D DiNardo, Kathleen J Propert, Alison W Loren, et al.
Leukemia Research|October 30, 2012
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosisAdi Diab, Lynette Zickl, Omar Abdel-Wahab, et al.
Blood|October 8, 2015
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemiasNicole Kucine, Sachie Marubayashi, Neha Bhagwat, et al.
Blood Advances|October 30, 2023
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 studyJessica K Altman, Tsila Zuckerman, Jamie Koprivnikar, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Nature|August 19, 2014
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemiaPanagiotis Ntziachristos, Aristotelis Tsirigos, G Grant Welstead, et al.
Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.
Blood Advances|May 7, 2025
Pivotal Results of SELECT-MDS-1 Phase 3 Study of Tamibarotene with Azacitidine in Newly Diagnosed Higher-Risk MDSAmy E DeZern, Sylvain Thepot, Stéphane De Botton, et al.
Pageof 29